Background: Gout is a disease caused by an overload of uric acid in the body, which leads to the formation of urate crystals that deposit in tissues, particularly in the joints. The deposition of these crystals causes recurring episodes of joint inflammation. This study aims to e...
Open access
Research Article10.9734/jamps/2025/v27i5777
Background: Tuberculosis (TB) is still one of the most important causes of morbidity and mortality worldwide. The problem multiplies whenever there is multidrug-resistant TB (MDR-TB), due to Mycobacterium tuberculosis susceptibility to both Rifampicin and Isoniazid. Pyrazinamide...
Open access
Research Article10.9734/jamps/2025/v27i12834
Sara S. Abdelrahim, Mohammed H. Alnazeer, Mawahib A. Mustafa, Safa A. Abdalla, Elkhanssa Abdelhameed Ahmed Elhag, Kannan O. Ahmed, Yasir S. Kheir, Elmoiz Babekir & Bashir A. Yousef·Journal of Advances in Medical and Pharmaceutical Sciences·2026
Background: Imatinib mesylate is a tyrosine kinase inhibitor that has transformed the treatment of chronic myeloid leukaemia. However, information on its real-world use among sub-Saharan African populations remains limited. Aims: This study evaluated early haematological response...
Open access
Research Article10.9734/jamps/2026/v28i8879